Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 285.67B, Merck(MRK) trades at $115.99. The stock has a price-to-earnings ratio of 32.41 and currently yields dividends of 2.9%.
Merck(MRK) stock opened on 2026-06-03 at $114.76. The price climbed to — and dipped to —.
The Merck(MRK)'s current trading volume is 117, compared to an average daily volume of 9.96M.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $75.44.
In the last year, Merck(MRK) shares hit a 52-week high of $125.14 and a 52-week low of $75.44.
MRK News
Key Points This biotech is making solid progress with several pipeline candidates. It could have a stronger lineup of approved products within a few years. 1...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Merck & Company, retaining the price target of $130.00. Unlock trusted, data-ba...
Moderna (MRNA) and Merck (MRK), known as MSD outside of the United States and Canada, announced detailed results from a planned five-year follow-up analysis of...
Analyst ratings
70%
of 30 ratingsMore MRK News
A promising new cancer drug helped reduce the risk of death by 34% in patients with the most common form of lung cancer, but investors appeared to be ambivalent...
Geoff Meacham, an analyst from Citi, maintained the Hold rating on Merck & Company. The associated price target remains the same with $125.00. Unlock trusted,...
Key Points An experimental lung cancer drug from Akeso and Summit Therapeutics improved survival in the Harmoni-6 Phase 3 trial conducted in China, according to...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near...
In May 2026, Merck & Co., Inc. received a positive CHMP opinion backing KEYTRUDA plus Padcev for certain bladder cancer patients in Europe and reported successf...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.